mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.2 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.2 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |